Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (91-100 of 361) with videos related to

Pageof 37
Sort By:
International Journal of Cancer|March 27, 2023
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trialElżbieta Senkus, Suzette Delaloge, Susan M Domchek, et al.
Familial Cancer|March 3, 2011
PALB2 mutations in familial breast and pancreatic cancerErin W Hofstatter, Susan M Domchek, Alexander Miron, et al.
Biomarker Research|January 8, 2026
Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutationsUrszula Smyczynska, Aleksander Rycerz, Klaudia Kozlowska, et al.
JAMA Network Open|February 18, 2025
Pathogenic Germline Variants in Patients With Metaplastic Breast CancerKaitlin Demarest, Arravinth Anantharajah, Kara N Maxwell, et al.
Cancer Research|August 16, 2008
The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer familiesMaurizia Dalla Palma, Susan M Domchek, Jill Stopfer, et al.
Journal of Translational Medicine|October 27, 2015
DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3Rachel L Yang, Rosemarie Mick, Kathreen Lee, et al.
Gynecologic Oncology|June 12, 2021
What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomyMartha Hickey, Katrina M Moss, Efrosinia O Krejany, et al.
Journal of the American College of Cardiology|January 19, 2019
Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer TherapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
Menopause (New York, N.Y.)|March 19, 2021
A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomyRakibul M Islam, Susan R Davis, Robin J Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer SusceptibilityMark E Robson, Angela R Bradbury, Banu Arun, et al.
Pageof 37

Showing results (91-100 of 361) with videos related to

Sort By:
Pageof 37
International Journal of Cancer|March 27, 2023
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trialElżbieta Senkus, Suzette Delaloge, Susan M Domchek, et al.
Familial Cancer|March 3, 2011
PALB2 mutations in familial breast and pancreatic cancerErin W Hofstatter, Susan M Domchek, Alexander Miron, et al.
Biomarker Research|January 8, 2026
Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutationsUrszula Smyczynska, Aleksander Rycerz, Klaudia Kozlowska, et al.
JAMA Network Open|February 18, 2025
Pathogenic Germline Variants in Patients With Metaplastic Breast CancerKaitlin Demarest, Arravinth Anantharajah, Kara N Maxwell, et al.
Cancer Research|August 16, 2008
The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer familiesMaurizia Dalla Palma, Susan M Domchek, Jill Stopfer, et al.
Journal of Translational Medicine|October 27, 2015
DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3Rachel L Yang, Rosemarie Mick, Kathreen Lee, et al.
Gynecologic Oncology|June 12, 2021
What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomyMartha Hickey, Katrina M Moss, Efrosinia O Krejany, et al.
Journal of the American College of Cardiology|January 19, 2019
Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer TherapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
Menopause (New York, N.Y.)|March 19, 2021
A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomyRakibul M Islam, Susan R Davis, Robin J Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer SusceptibilityMark E Robson, Angela R Bradbury, Banu Arun, et al.
Pageof 37